Background: The early B lymphopoiesis in mammals is regulated through close interactions with stromal cells and components of the intracellular matrix in the bone marrow (BM) microenvironment. Although B lymphopoiesis has been studied for decades, the factors that are implicated in this process, both autocrine and paracrine, are inadequately explored. Wnt signaling is known to be involved in embryonic development and growth regulation of tissues and cancer. Wnt molecules are produced in the BM, and we here ask whether canonical Wnt signaling has a role in regulating human BM B lymphopoiesis.
Background
In mammals, the early antigen independent phase of B lymphopoiesis takes place in the intersinusoidal spaces in the bone marrow (BM). Here, the B cell progeny mature from hematopoietic stem cells (HSC) via early lymphoid progenitors (ELP, comprising common lymphoid progen-itors and early B), pro-B, pre-B and immature B developmental stages characterized by successive steps in the rearrangement of immunoglobulin genes and consecutive expression of cellular markers [1] [2] [3] . Using immunohistochemical doublestaining we have revealed earlier that all developmental stages of the B cell lineage in human BM tissue are in close contact with slender CD10 + stromal cells or their extensions [4] . This finding correlates with the consensus that B lymphopoiesis is tightly regulated by signals provided by mesenchymal stromal cells and components of the intracellular matrix in the BM microenvironment in vivo [4] [5] [6] . However, the elements of this signaling are yet inadequately identified; stromal factors like IL 7, Flt3 ligand [7] , IL-3 [8, 9] and SDF1 [10, 11] are essential, but not sufficient for BM B lymphopoiesis [2] . Clearly, there is a need for further characterization of both the stromal phenotype as well as the autocrine and paracrine factors that participate in the regulation of BM B lympopoiesis.
Wnt proteins belong to a large and highly conserved family of secreted, cystein-rich glycoprotein signaling molecules, consisting of 19 members. They are likely to act locally because of their limited solubility [12] and tendency to associate with the cell surface extracellular matrix [13] . Signaling is initiated by Wnt proteins binding to receptors of the Frizzled family (Fzd) on the cell surface. This binding is promiscuous and the ligand/receptor specificities are not yet properly determined. Depending on particular Wnt/Fzd combinations, at least three signaling cascades may be activated. Most studied is the canonical Wnt pathway, which is activated by members of the Wnt1 class (such as Wnt1, Wnt2, Wnt3 and Wnt8) [14] . A key regulatory molecule in this pathway is β-catenin, which in the absence of a Wnt signal is kept low through continuous phosporylation by glycogen synthase kinase-3β (GSK-3β), resulting in a subsequent proteasome dependent destruction of β-catenin. Binding of Wnt ligands to Fzd receptors and coreceptors LRP5/6, leads to inactivation of GSK3β and thereby accumulation of nonphosphorylated β-catenin, which enter the nucleus. Here, β-catenin acts as a coactivator of members of the lymphoid enhancer factor-1 (LEF-1)/T-cell factor (TCF) family of transcription factors to stimulate transcription of Wnt target genes [15] . Activation of Wnt signaling can be inhibited by soluble antagonists, including the Dickkopf (Dkk) family and the soluble Fzd related proteins (sFRP) [16] .
Recently, Wnt proteins have drawn attention as a set of factors operating in embryonic development, growth regulation of adult tissues and cancer formation [15, [17] [18] [19] [20] . Moreover, Wnt signaling plays a central role in the communication between HSC and stromal cells [21] as well as in several other stem cell niches [22, 23] . Several observations have established direct roles for Wnt signaling in the maturation process where hematopoietic stem cells lose their pluripotency and commit to specific lineages [24] [25] [26] . LEF-1 and Fzd9 knockout mice show defect B lymphopoiesis [24, 27] and Wnt signaling seems to be involved in development of leukemia [28] [29] [30] and malignant myeloma [31] . Moreover, in murine B lymphopoiesis this signaling pathway has a stimulatory effect on pro-B cells from fetal liver [24] . As early B lymphopoiesis in mice and humans to a certain extent shows distinct factor dependency [32] , and since fetal and adult lymphopoiesis takes place in different maturation niches, the aim of the present study was to investigate Wnt signaling in human BM B lymphopoiesis in more detail. We have examined which Wnt signaling pathway molecules that are expressed in B progenitor cells and stromal cells from human BM, and analyzed the regulated expression of several Wnt receptors (Fzd and LRP), β-catenin and plakoglobin as well as the central transcription factors LEF-1 and TCF-4 during the early B lymphopoiesis. Furthermore, we have investigated the effect of recombinant Wnt3A on progenitor B cells. We found that Wnt3A induced β-catenin stabilization and inhibited in vitro B lymphopoiesis in a coculture with stromal cells by suppression of initial cell proliferation. Thus, canonical Wnt signaling may be involved in human BM B lymphopoiesis.
Results

A distinct set of Wnt ligands, Fzd receptors and Wnt antagonists is expressed in B progenitor cells and stromal cells from human BM
Previous work has demonstrated expression of Wnt5A, Wnt2B and Wnt10B in pooled human BM populations [26] . However, the expression pattern of Wnt ligands, Fzd receptors and Wnt antagonists in human B lineage cells has not been explored. In the absence of available antibodies to detect these large families of proteins, we performed conventional RT-PCR on RNA isolated from FACS sorted B progenitor cells (CD10 + IgM -CD45 + ) pooled from three different donors, using primers designed specifically to detect mRNA expression of all known Wnt ligands and Fzd receptors as well as the Wnt antagonists Dkk1, Dkk4, sFRP1-4 and WIF1 ( fig. 1 and table 1 ). In B progenitor cells, Wnt 2B, 5B, 8A, 10A and 16 mRNAs were readily detected. Interestingly, the Wnt16 PCR product had two bands of 520 bp and 233 bp, respectively ( fig. 1 ). The 520 bp band represents the full-length form and the 233 bp band represents a possible splice variant lacking exon 3, potentially giving rise to a truncated Wnt16 form. In addition, expression of several other Wnt mRNAs was detectable, however, less readily ( Real-time PCR analysis of relative mRNA expression levels of Wnt pathway molecules in BM B progenitor sub-populations LEF-1 and TCF-4 mRNA expression is highly regulated during the early B lymphopoiesis, as shown previously by microarray analysis (Hystad ME et al, manuscript in preparation and [33] ). Our results showed a strong up-regulation of LEF-1 mRNA as the cells commit to the B lineage, and the expression was kept continuously high until the cells become immature B cells, where the level was reduced to the same as in uncommitted progenitors. Here, low LEF-1 expression was further confirmed by the absence of LEF-1 protein in B lymphocytes from peripheral blood (results not shown). The relative TCF-4 mRNA levels, on the other hand, were high in both ELP and pro-B, and decreased (up to 5-fold) as the cells passed through Ig rearrangement (pre-B -immature B cells) ( fig. 2 ). It should be noted that the LEF-1 mRNA expression was detected 5-8 cycles earlier than the TCF-4 mRNA expression, indicating that LEF-1 mRNA is much more abundant than TCF-4 mRNA.
Wnt3A induces β-catenin stabilization and accumulation in BM B progenitor cells
Our data demonstrated that human BM B progenitor cells express a set of central players in the canonical Wnt signaling pathway, potentially allowing a Wnt signal to be conveyed. To further examine whether B progenitor cells could respond to treatment with Wnt proteins, we looked for the stabilization and subsequent accumulation of the vital signaling molecule β-catenin in CD10 + B progenitor cells. When these cells were treated with Wnt3A, the amount of β-catenin increased substantially compared to the very low levels in untreated cells ( fig. 3 ). Although there were some donor variations, the results showed that the B progenitor cells are able to receive and communicate a signal from the Wnt pathway.
Wnt3A inhibits human in vitro B lymphopoiesis
Having identified expression of central molecules in the canonical Wnt pathway in BM B progenitor cells, we performed two variants of B lymphopoiesis assays to investigate whether Wnt signaling (using recombinant Wnt3A) had a functional effect on B lymphopoiesis in vitro. Both assays were based on coculture with the murine stromal cell line MS-5. In assay 1 hematopoietic progenitor cells (HPC) were tested for their capacity to develop into B lineage cells, whereas in assay 2 B progenitor cells were measured for survival and expansion. At the endpoint of the assays, each sample was subjected to quantitative flow cytometry and the total number of cells positive for the pan B cell marker CD19 was measured. In assay 2, analysis of the differentiation marker CD34 was included.
Initial analyses demonstrated that Wnt3A had an inhibitory effect when BM HPC (CD133 + CD10 -) were grown on stromal cells for 3 weeks at conditions that favored B lymphopoiesis (assay 1). The number of CD19 + cells in the samples treated with Wnt3A was 5 times less than the number measured in the control samples ( fig. 4A ). The inhibited B lymphopoiesis could result from Wnt3A suppressing differentiation of the HSC pool found in the HPC population [34] , an indirect effect mediated by the stromal cells [35] , or, alternatively, Wnt3A could target more committed lymphoid progenitor cells. To examine the latter possibility in more detail, we tested whether Wnt3A acted on later stages of in vitro B lymphopoiesis. BM B progenitor cells (CD10 + ) were grown on stromal cells in the presence of Wnt3A or medium only for 2 weeks (assay 2). In accordance with the results from the assays using HPC, it was demonstrated on average near 50% reduction in the total number of CD19 + cells in samples treated with Wnt3A compared with control ( fig. 4B ). When added every third day, both sFRP1 and Dkk1 were able to counteract the effect of Wnt3A almost completely, demonstrating a specific effect of Wnt3A on in vitro B lymphopoiesis ( fig. 4B ). Similar results were obtained using Wnt3A protein from another source; Wnt3A conditioned medium (table 2) . Moreover, the effect was independent of the source of stromal cells as the use of primary human BM stromal cells (BMS) as supportive layer did not change the outcome of the experiment (table 2) . To check whether Wnt3A affected distinct early B subpopulations differently, the cells in assay 2 were additionally analyzed for expression of the CD34 differentiation marker to distinguish between pro-B and pre-B cells. The relative frequency of CD34 + cells (pro-B) decreased from 38 % before culturing (day 0), to approximately 30 % and 15 % after one and two weeks of culturing, respectively. This decrease was independent of treatment with or without Wnt3A ( fig. 4C ). Furthermore, separation of the pre-B population into large cycling and small resting pre-B cells by surface expression of CD20 [33] revealed inhibitory effect of Wnt3A on all subpopulations (results not shown). Thus, we conclude that Wnt3A does not affect the relative proportions of different BM B subpopulations, but has a general inhibitory effect on pro-B, pre-B and immature B cells in a stroma coculture.
Wnt3A inhibits BM B progenitor cell division in vitro
The inhibitory effect of Wnt3A on in vitro B lymphopoiesis could be explained by increased apoptosis, an inhibitory effect on proliferation, or both. However, measurements of apoptosis in cells cultured without stromal cells for 1, 2 or 3 days showed no effect of Wnt3A (results not shown), suggesting an effect on proliferation only. To verify this, we used high-resolution cell division tracking to study the initial effects of Wnt3A on B progenitor cells grown on a stromal layer. 
Discussion
Several studies have identified the canonical Wnt pathway as a regulator of the homeostasis of human and murine HSC and hematopoietic progenitor cells [26, 34, 36] . Furthermore, knockout studies (LEF-1 and Fzd9) in mice have indicated a central role for Wnt signaling in B lymphopoiesis [24, 27] . The Wnt pathway also seems to be involved in development of leukemia [28] [29] [30] . . This is partly in accordance with previous studies [24, 26] . Taken together, these results show that both Wnt3A inhibits the initial phase of stromal supported cell division of BM B progenitors [27] . In contrast to this, our results show that the large cycling pre-B cells express lower levels of LRP5, LRP6, Fzd6, Fzd9, β-catenin and plakoglobin than the small resting pre-B cells. Although one should be cautious in trying to predict functional consequences from mRNA expression data, this trend suggests that Wnt signaling is not likely to be involved in a positive regulation of cycling of the large pre-B cells after Ig heavy chain rearrangement. And even though the absolute expression levels of the receptor mRNAs are low, these data suggest that during a narrow window of the development comprising pro-and pre-B cells, B progenitor cells might be target for Wnt signaling through these receptors.
To be able to convey a Wnt-signal, the cells have to express either of the two important molecules, β-catenin or plakoglobin. Our results show that levels of β-catenin mRNA change little during the differentiation. Although it has been demonstrated that levels of cytoplasmic β-catenin protein may vary throughout the development of thymocytes [37] , these variations may not necessarily be reflected by the mRNA levels. In fact, as β-catenin is needed both for signaling purposes as well as for adhesion purposes, the mRNA levels may have to be kept relatively stable. Plakoglobin mRNA, on the other hand, decreases after the pro-B differentiation level. This corresponds to the observations made in developing murine thymocytes [37] , where plakoglobin is down-regulated at the level of immature single positive thymocytes, suggesting that plakoglobin may play a central, but hitherto unexplored role in conveying a Wnt signal during lymphopoiesis. In fact, the lack of effect of knocking down β-catenin in early hematopoiesis, including B and T lymphopoiesis [38] , prompted the authors to suggest that plakoglobin may stand-in for β-catenin in this respect.
The LEF-1/TCFs are directly activated by canonical Wnt signaling, and LEF-1 knockout mice show defects in pro-B cell proliferation and survival [24] . However, it cannot yet be ruled out that this effect might be a result of abolishment of the repressive functions or other non-Wnt related activities of LEF-1 [15] . Here, we have verified microarray data showing regulation of LEF-1 and TCF-4 during B lymphopoiesis (Hystad ME et al, manuscript in preparation and [33] ). Interestingly, it has been reported that LEF-1 is a target gene for the B lymphopoiesis key transcription factor Pax-5 [39] . Moreover, LEF-1 interacts with Pax-5 and c-Myb to activate the Rag-2 promoter [40] , but the accurate role of LEF-1 in B lymphopoiesis is still elusive. In contrast to LEF-1, we found TCF-4 mRNA levels to be high in ELP and pro-B cells, and lower in the more mature pre-B and immature B populations. Although expressed at lower levels, one could speculate that TCF-4 steps in for LEF-1 in the earliest lymphoid progenitors before LEF-1 is properly switched on, potentially in conveying a Wnt signal or, alternatively, in acting as a transcription repressor of B lineage genes before commitment. These are topics for further studies.
Wnt antagonists play important roles in preventing or fine tuning the Wnt signal [16] . Our data show expression of the Wnt antagonists Dkk1, Dkk4, sFRP4 and WIF1 mRNAs in B progenitor cells. Dkk1, sFRP2 and sFRP3 were expressed in bone marrow stromal cells. Of these factors, Dkk1 in particular is known to be involved in a feedback loop to adjust or shut down canonical Wnt signaling [41] . It is likely that these factors are important in adjusting the incoming Wnt signals in the bone marrow microenvironment, where several cell types are able to express a wide range of ligands and Wnt receptors.
The inhibitory effect of Wnt3A on the generation and cell division of B progenitor cells in vitro, both with regard to pro-and pre-B cells, is in contrast to several reports on the functional effects of canonical Wnt signaling in mice. Both in murine HSC [34] , developing thymocytes [25] and a wide range of cancer cells [31, 42] , elevated levels of β-catenin lead to increased cell proliferation. Furthermore, in fetal murine pro-B cell [24] , Wnt3A conditioned medium leads to increased BrdU incorporation. Our divergent results may be due to different species, microenvironments and/or cell context. For instance, murine and human B lymphopoiesis require to a certain extent differing factor dependency [32] . However, by culturing murine BM B progenitor cells, we have not been able to demonstrate increased cell proliferation in the presence of Wnt3A (results not shown). Thus, we suspect the Wnt response to be different in fetal and adult B progenitor cells, potentially affected by the cellular microenvironment and/or context. Indeed, the fetal pro-B cells are exposed to the microenvironment of the liver and this is very different from that of the BM. For instance several regulators of the Wnt pathway are more highly expressed in fetal liver stroma than in BM stroma [43] , which suggest that Wnt signaling might be regulated in a different manner and have a different role in the fetal liver than in the BM. Another important aspect that has to be taken into consideration, is that different Wnt ligands, although able to activate canonical Wnt signaling, indeed show distinct activities [44] . In addition there may also be species and location differences. However, as mentioned above, Cobas et al have demonstrated a lack of an essential role for β-catenin in BM hematopoiesis, including proliferation of B lymphocytes [38] . Thus, in contrast to findings in the fetal liver, our results may very well represent a physiological situation in the adult organism, where Wnt signaling via β-catenin is not essential for B lymphocytes, but may be used to fine tune the delicate balance between proliferation, differentiation and apoptosis taking place during early BM B lymphopoiesis.
In support of our data on an inhibitory effect of Wnt3A on cell division, it has been reported that canonical Wnt signaling hampers fibroblast cell proliferation through cell cycle blocks, potentially mediated via p53 [45] . Moreover, Wnt signaling inhibits proliferation and regulates cellcycle arrest at distinct stages of development in Drosophila wing development [46] . Thus, it is likely that the cellular context, in some cases represented by the ability of a central regulatory molecule like p53 to respond, will affect how the cells react to vital stimuli like Wnt. It has been speculated that aberrant p53 is necessary to convey the strong tumor promoting effect of abnormal Wnt signaling seen in colon cancer [47, 48] . It is also interesting that Wnt5A has been found to inhibit B cell proliferation and can function as a tumor suppressor in hematopoietic tissue, albeit via the non-canonical Wnt/Ca 2+ pathway [49] . [35] . The BM microenvironment is composed of a heterogeneous population of cells including fibroblasts, adipocytes, endothelial cells and osteoblasts, all derived from a common mesenchymal precursor [50] . In particular, the role of Wnt signaling in adipogenesis may be relevant here, as it has been demonstrated that Wnt10B [51, 52] inhibits adipogenesis, and there seems to be a positive correlation between adipogenesis and hematopoiesis [52] . This emphasizes the complexity of the interactions in the B lymphopoiesis maturation niche and opens for the possibility that B progenitor cells may manipulate the stromal support via these Wnt factors. However, it is not uncommon in developmental niches that morphogenic signals have the potential to act on several cells in the microenvironment. Therefore, it has been suggested that Wnt signaling might influence the HSCs both directly and indirectly by maintenance of the cellular elements of the stem cell niche [21] . In line with this theory, several studies have demonstrated expression of multiple Wnt mRNAs in thymocytes and the thymic microenvironment. It is likely that particular Wnts serve distinct roles, thus, cell specific effects may be achieved by "playing the Wnt repertoire" as well as through combinations with other signaling events.
Conclusion
In this study, we have demonstrated mRNA expression of several Wnt ligands, Fzd receptors and Wnt antagonists in human BM B progenitor cells and regulated expression of Fzd receptors and co-receptors, β-catenin, plakoglobin, LEF-1 and TCF-4 mRNA in these cells during differentiation. Furthermore, we find that Wnt3A induced an accumulation of β-catenin in the BM B progenitor cells and inhibition of in vitro B lymphopoiesis. These results suggest the Wnt/β-catenin pathway as a negative regulator of human stromal dependent B lymphopoiesis. This is in contrast to observations on Wnt effects in fetal murine pro-B cells, and may represent a distinction between the fetal liver and adult BM microenvironments.
Methods
Reagents and antibodies for FACS and western blot analysis
Recombinant murine (rm) Wnt3A, recombinant human (rh) secreted frizzled related protein 1 (sFRP1), rh Dickkopf 1 (Dkk1), rh interleukin (IL)-7, rh IL-3 and rh Flt3 ligand (FL) were purchased from R&D Systems (Great Britain). The following monoclonal antibodies (mAbs) were used for flow cytometry: anti-CD34 PE, anti-CD10 APC, anti-CD10 PE-Cy7 and anti-CD20 APC from Becton Dickinson, Biosciences Pharmingen (San Jose, CA, USA), anti-CD19 PE-Cy5 and anti-CD34 PE-Cy5 from Immunotech (Marseille, France) and anti-CD19 PE, anti-CD45 PE and anti-IgM Fitc from Dako Cytomation (Denmark). Irrelevant isotype matched Abs were used as controls. The following Abs were used in western blot analysis: anti-β-catenin (Mouse IgG1, BD Transduction Laboratories), anti-β-actin (Goat polyclonal IgG, Santa Cruz Biotechnology), rabbit anti-mouse IgG1-HRP and rabbit anti-goat IgG-HRP (Dako cytomation, Denmark).
Primary cells and cell lines
BM aspirates were from the iliac crest of normal adult volunteers (approved by the Regional Ethical Committee). Mononuclear cells (MNC) were separated by FicollHypaque density gradient centrifugation (Lymphoprep, Nycomed, Norway). CD10 + B progenitor cells (ELP, pro-B and pre-B cells) were isolated from BM MNC using Dynabeads ® M-450 Epoxy (Dynal, Oslo, Norway) directly coated with anti-CD10 mAb (clone RFAL-3, SigmaAldrich, UK) followed by detachment using CD4/CD8 DETACHaBEAD (Dynal, Norway) according to the producer 's protocol. The CD10 + cells were of 90-95% purity, they were CD45 + and contained 4-7% IgM + cells (immature B cells). CD34 + and CD19 + cells were isolated in a similar manner from MNC using Dynabeads ® M-450 conjugated with anti-CD34 or anti-CD19 mAb, respectively, and CD34 or CD19 DETACHaBEAD (Dynal, Norway), respectively. CD133 + CD10 -cells (HPC) were isolated from the CD10 -fraction of BM MNC (see above) using the MACS system (Magnetic cell sorting of human cells) and a CD133 Cell Isolation Kit (Miltenyi Biotec, Germany). Briefly, the mononuclear cells were magnetically labeled with CD133 MicroBeads and separated on a column, which was placed in the magnetic field of a MACS Separator. The magnetically labeled CD133 + cells were retained in the column while the unlabeled CD133 -cells passed through. After removal of the column from the magnetic field, the magnetically retained CD133 + cells were eluted as the positively selected cell fraction. The CD133 + cells were typically of 97-98% purity. In monoculture, the cells were kept in X-VIVO 15™ (BioWhittaker, Walkersville, USA) with 0.1% detoxified BSA.
The murine stromal cell line MS-5 [53] was cultured in α-MEM with 10% FCS and 100 µg/ml of penicillin and streptomycin (PAA Laboratories, Pasching, Austria) and was passaged twice a week. Cultures of human BM stromal (BMS) cells were established as previously described [54] . Briefly, total BM MNC cells depleted of CD34 + cells were seeded into 75-cm 2 tissue culture flasks in RPMI-1640 with 10% FCS, penicillin and streptomycin. Nonadherent cells were washed off after 2 hours at 37°C, and the adherent cells were cultured in EX-CELL 610 (JRH Biosciences, USA) with 10% FCS, penicillin and streptomycin. The BMS cells were passaged twice before they were used for experiments.
The human ALL cell lines Reh (no ACC 22, DSMZ) and Nalm-6 (no ACC 128, DSMZ) (Hurwitz et al, 1979) were kept in X-VIVO 15™ supplemented with 100 µg/ml of penicillin and streptomycin. 
FACS analysis and cell sorting
PCR analysis
Total RNA from freshly isolated and sorted BM CD45 + CD10 + IgM -cells was isolated using Absolutely RNA™ RT-PCR Mini-prep kit (Stratagene Europe, Amsterdam, Netherland) according to the manufacturer's instructions. RNA from human fetal brain was purchased from BioChain Institute, Inc., USA. cDNA was synthesized from 1 µg total RNA primed with random hexamers in a 50 µl reaction using TaqMan Reverse Transcription Reagents (Applied Biosystems, Foster City, CA, USA). Control reactions lacking reverse transcriptase were always included. RT-PCR of 20 ng of total RNA was performed with a titanium polymerase (BD Biosciences, USA) in a 25 µl reaction for 37 cycles at 95°C for 30 seconds, 60°C for 30 seconds, and 68°C for 30 seconds. The primer sequences used to identify Wnt, Fzd and Wnt antagonist gene expression are listed in Table 3 . The primer sequences was partly designed specifically for this work and partly copied from previous expression analyses [55] . For all mRNAs expressed, the amplified products have been sequenced and confirmed to represent the correct target gene. cDNAs were synthesized from total RNA primed with random hexamers using TaqMan Reverse Transcription Reagents (Applied Biosystems, Foster City, CA, USA). LEF-1 and TCF-4 (gene name TCF-7L2) mRNA expression was analyzed by real-time quantitative RT-PCR using Taqman technology according to the manufacturers procedure (Applied Biosystems). Predeveloped assay reagents including primers and probes for LRP5 (Hs00182031_m1), LRP6 (Hs00233935_m1), Fzd2 (Hs00361432_s1), Fzd5 (Hs00361869_g1), Fzd6 (Hs00171574_m1), Fzd9 (Hs00268954_s1), β-catenin (CTNNB1, Hs00170025_m1), plakoglobin (JUP, Hs00158408_m1), LEF-1 (Hs00212390_m1) and TCF-4 (Hs00181036_m1) mRNAs as well as the endogenous control phosphoglycerate kinase 1 (PGK1) (Hs99999906_m1) were supplied by Applied Biosystems and the PCR reactions were performed according to the manufacturer's instructions using Taqman Universal PCR Master Mix. Each measurement was performed in duplicate and the expression level for each gene was calculated using the standard curve method for relative quantitation of gene expression as described by the manufacturer (ABI Prism 7700 Sequence Detection System, User Bulletin 2, PE Applied Biosystems, Foster City, CA). Total RNA from the ALL cell lines Reh and Nalm6 as well as total RNA from human fetal brain were used for standard curves. Expression values for PGK1 mRNA, initially determined to be a suitable endogenous control for BM populations, were used for normalization of the expression levels. The expression level of the different genes in pro-B cells was used as a calibrator, and the expression of the other populations were calculated relative to the expression in pro-B cells.
Real-time PCR
Western blot analysis
The cells were treated with Wnt3A or vehicle only (PBS with 0.1% detoxified BSA) for 3 hours and total cell lysates were analyzed by Western blot using 10% SDS polyacrylamide gels from Pierce (Rockford, USA) as described earlier [56] . The filters were pretreated with PBS containing 0.1% Tween-20 (PBS-T) and 5% dry milk, incubated overnight with anti-β-catenin Ab or 1 hour with anti-β-actin Ab and then washed 2 × 15 min in PBS-T. The filters were then incubated with the secondary Ab rabbit anti-mouse IgG1-HRP Ab or rabbit anti-goat IgG-HRP Ab, respectively, for 60 minutes at room temperature and washed 2 × 15 min in PBS-T before the proteins were visualized using ECL + Western Blotting Detection Reagents from Amersham Biosciences (Piscataway, NJ, USA). . Both sets of cocultures were in α-MEM containing 1% FCS, 100 µg/ml of penicillin and streptomycin, and supplemented with cytokines (for HPC: SCF, 25 ug/ml and G-CSF, 2,5 ug/ml, for B progenitor cells: IL-7, 50 ng/ml, IL-3, 20 ng/ml and FL, 50 ng/ml). In one additional experiment, the wells were pre-seeded with BMS (1 × 10 4 cells/well) in EX-CELL 610 with 1% FCS, 100 µg/ml of penicillin and streptomycin and cytokines (IL-7, 50 ng/ml, IL-3, 20 ng/ml and FL, 50 ng/ml). Where indicated, Wnt3A (10-100 ng/ml), Dkk1 (500 ng/ml) or sFRP1 (2 µg/ml) were added to the cultures. 50% of the medium was replaced weekly. After 3 (HPC) or 2 (B progenitor cells) weeks of culturing, single wells were harvested by trypsination and the B progenitor cells were immunophenotyped using the pan B cell marker CD19 as well as the CD34 differentiation marker and subjected to quantitative analyses (see above). Wnt3A conditioned medium and control medium were collected from L-Wnt3A cells and control nontransfected L-cells, respectively (purchased from American Type Culture Collection (ATCC), Manassas, USA), according to the manufacurer's procedure. High-resolution cell division tracking BM CD34 + and CD19 + cells were labeled with 5-and 6-carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes, Eugene, OR, USA) as described earlier [57] . To allow unbound dye to diffuse from cells, labeled cells were seeded on a confluent layer of MS-5 and incubated for 18-24 hours at 37°C in α-MEM with 1% FCS. Subsequently, the cells were stained with CD10 APC mAb and CD10 + CFSE mean cells were sorted on a BD FACSDiVa flow cytometer (Becton Dickinson). Sorted cells (1.5-2 × 10 4 /well) were cultured in 48 well tissue plates pre-seeded with MS-5 (2 × 10 4 cells/well) supplemented with IL-7 (50 ng/ml) and FL (50 ng/ml) and treated with Wnt3A (25-400 ng/ml), Wnt3A + sFRP1 (2 µg/ml) or medium only. IL-3 was left out of these cultures, because earlier experiments showed that IL-7 and FL were sufficient to support survival and proliferation of the B progenitor cells (data not shown). After three days the cells were harvested by trypsination and analyzed on a FACSCalibur flow cytometer for the number of cell divisions as well as expression of the cell surface markers CD34 and CD19.
Statistical analysis
The statistical significance of differences between groups was determined using the paired two-tailed Wilcoxon's nonparametric test, by applying SPSS 11.5 software. 
